Skip to main content

Osteoarthritis of Hip

0
Pipeline Programs
3
Companies
6
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Zimmer Biomet
Zimmer BiometFL - Jacksonville
4 programs
ArCom® PolyethyleneN/A1 trial
Bioguard GroupN/A1 trial
Hip replacementN/A1 trial
Total Hip ArthroplastyN/A1 trial
Active Trials
NCT00565786Completed150Est. Jan 2020
NCT02263209Active Not Recruiting50Est. May 2025
NCT00551967Unknown50Est. Dec 2022
+1 more trials
Corin
CorinUK - Cirencester
1 program
Clinical and Radiographic Outcomes of the Corin Tri-Fit Total Hip ReplacementN/A1 trial
Active Trials
NCT02162186Completed37Est. Dec 2019
Innovation Pharmaceuticals
1 program
HIT Hip Replacement SystemN/A1 trial
Active Trials
NCT02836262Recruiting100Est. Aug 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Innovation PharmaceuticalsHIT Hip Replacement System
CorinClinical and Radiographic Outcomes of the Corin Tri-Fit Total Hip Replacement
Zimmer BiometBioguard Group
Zimmer BiometTotal Hip Arthroplasty
Zimmer BiometHip replacement
Zimmer BiometArCom® Polyethylene

Clinical Trials (6)

Total enrollment: 1,387 patients across 6 trials

NCT02836262Innovation PharmaceuticalsHIT Hip Replacement System

Hip Replacement System (HRS-P) in Primary Total Hip Arthroplasty

Start: Aug 2017Est. completion: Aug 2026100 patients
N/ARecruiting
NCT02162186CorinClinical and Radiographic Outcomes of the Corin Tri-Fit Total Hip Replacement

Clinical and Radiographic Outcomes of the Corin Tri-Fit Total Hip Replacement

Start: Oct 2014Est. completion: Dec 201937 patients
N/ACompleted
NCT02263209Zimmer BiometBioguard Group

Investigation to Determine Safety of Taperloc Stems With BioGuard Coating When Used in Cementless Total Hip Arthroplasty

Start: Oct 2013Est. completion: May 202550 patients
N/AActive Not Recruiting
NCT00545285Zimmer BiometTotal Hip Arthroplasty

Long-Term Multi-center Evaluation of E-Poly and Regenerex

Start: Nov 2007Est. completion: May 20231,000 patients
N/AUnknown
NCT00551967Zimmer BiometHip replacement

Evaluation of the Wear of Vitamin E Treated Polyethylene Components in Primary THA Using RSA

Start: Oct 2007Est. completion: Dec 202250 patients
N/AUnknown
NCT00565786Zimmer BiometArCom® Polyethylene

ArCom® and ArComXL® Polyethylene Data Collection

Start: Jul 2004Est. completion: Jan 2020150 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 1,387 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.